Appendix from Results of the ADAPT Phase 3 Study of Rocapuldencel-T in Combination with Sunitinib as First-Line Therapy in Patients with Metastatic Renal Cell Carcinoma
Year: 2023
Type: other
Abstract: ADAPT study group and participating centers
Authors: Robert A. Figlin, Nizar M. Tannir, Robert G. Uzzo, Scott S. Tykodi, David Y.T. Chen, Viraj Master, Anil Kapoor, Daniel Vaena, William Lowrance, Gennady Bratslavsky, Mark DeBenedette, Alicia Gamble, Ana Plachco, Marcus S. Norris, Joe Horvatinovich, Irina Y. Tcherepanova, Charles A. Nicolette, Christopher G. Wood
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362142197